查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1908594

伴侶動物骨關節炎市場規模、佔有率和趨勢分析報告：按產品、動物、給藥途徑、分銷管道、地區和細分市場預測（2026-2033 年）

Companion Animal Osteoarthritis Market Size, Share & Trends Analysis Report By Product, By Animal, By Route Of Administration, Distribution Channel, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

伴侶動物骨關節炎市場概覽

2025年全球伴侶動物骨關節炎市場規模估計為29.8億美元，預計2033年將達到52.2億美元。

預計從 2026 年到 2033 年，該市場將以 6.46% 的複合年成長率成長。主要市場促進因素包括寵物護理的進步、寵物擬人化程度的提高和寵物消費的增加、支持計劃和舉措，以及全球寵物數量動態的變化。

伴侶動物骨關節炎（OA）治療的進展正在改變獸醫學的模式。隨著獸醫學的不斷進步，骨關節炎的新治療方法和治療方法變得更加精準有效，從而改善了疾病的整體管理，並提高了患病寵物的生命品質。

更有效的藥物、生技藥品和非藥物療法的研發在這一發展過程中發揮關鍵作用。例如，近年來，再生醫學，包括幹細胞療法和富血小板血漿（PRP）療法，越來越受到關注。這些療法在減輕骨關節炎關節發炎和促進癒合方面已顯示出令人鼓舞的效果。這些治療方法在獸醫實踐中越來越受歡迎，為寵物飼主提供了更多有效的治療選擇。根據美國獸醫協會（AVMA）2024年2月發表的一篇報導，再生醫學的進步顯著改善了骨關節炎等關節疾病的治療，有助於緩解寵物疼痛并提高其活動能力。此外，精準醫療的興起，即根據個別寵物的需求量身定做治療方案，也有助於最佳化骨關節炎的治療管理。

這種方法能夠實現更精準的診斷，並允許採用針對骨關節炎特異性病因而非僅僅緩解症狀的治療方法。隨著獸醫行業不斷朝著更專業和個人化的護理模式發展，這些進步有望持續改善患有骨關節炎的寵物的治療效果。 2023年5月5日，美國食品藥物管理局（FDA）核准了Librera（bedinvetomab）用於治療犬骨關節炎相關疼痛。這項核准標誌著獸醫疼痛管理領域的重要進展，使Librera成為美國首個也是目前唯一一個用於治療犬骨關節炎疼痛的每月一次的抗神經生長因子（NGF）單株抗體藥物。此外，創新動物用藥品和治療方法的核准在推進伴侶動物骨關節炎的治療方面發揮關鍵作用。與其他獸醫領域類似，美國FDA等監管機構正擴大核准旨在改善關節健康的治療方法。

獸醫護理成本的上漲和寵物健康意識的增強，促使人們更加關注骨關節炎治療領域的創新，從而推動了對先進解決方案的需求。寵物飼主越來越願意投資於能夠改善寵物生活品質的先進療法，這進一步促進了骨關節炎護理市場的成長。根據Talker Research為MetLife進行的一項調查，預計到2024年，寵物飼主在寵物身上的平均支出將達到2,085.60美元。儘管通貨膨脹加劇，但仍有36%的受訪者預計2025年的支出將更高，顯示人們越來越願意在寵物健康方面進行投資。

這些持續的進步，加上寵物保險的日益普及和人們對動物健康的日益關注，預計將進一步推動對創新骨關節炎療法的需求。隨著獸醫保健領域的不斷發展和新技術的湧現，伴侶動物骨關節炎的治療能力將不斷提高，從而推動這個專業市場的進一步擴張。

目錄

第1章調查方法和範圍

第2章執行摘要

3. 伴侶動物骨關節炎市場的趨勢與範圍

  • 市場體系展望
    • 母市場
    • 相關市場
  • 市場動態
  • 伴侶動物骨關節炎市場分析工具
    • 波特五力分析
    • PESTEL 分析與 SWOT 分析
  • 主要國家和物種的動物數量估計（2021-2024 年）
  • 產品平臺分析

第4章 伴侶動物骨關節炎市場：產品、估算與趨勢分析

  • 伴侶動物骨關節炎市場：依產品分類的差異分析
  • 伴侶動物骨關節炎市場規模及產品趨勢分析（2021-2033）
  • 生技藥品
    • 幹細胞
    • 富血小板血漿（血小板血漿）
    • 單株抗體（mAbs）
    • 其他生技藥品
  • 黏性補充劑
  • 製藥
    • 類固醇
    • 非類固醇消炎劑（NSAIDs）
    • 其他
  • 營養補充品
    • 軟骨素
    • 葡萄糖胺
    • 甲基磺醯甲烷（MSM）
    • 透明質酸（HA）
    • Omega-3脂肪酸
    • 其他

第5章 伴侶動物骨關節炎市場：按物種分類的估計和趨勢分析

  • 伴侶動物骨關節炎市場：依動物類型分類的差異分析
  • 伴侶動物骨關節炎市場規模及趨勢分析（依動物種類分類，2021-2033 年）
  • 狗
  • 貓
  • 馬

6. 伴侶動物骨關節炎市場：依給藥途徑分類的估算與趨勢分析

  • 伴侶動物骨關節炎市場：依給藥途徑分類的差異分析
  • 伴侶動物骨關節炎市場規模及趨勢分析（依給藥途徑分類，2021-2033 年）
  • 口服
  • 注射
    • 肌肉內注射
    • 關節內
    • 其他注射藥物
  • 其他

7. 伴侶動物骨關節炎市場：按通路分類的估算與趨勢分析

  • 伴侶動物骨關節炎市場：按通路分類的差異分析
  • 伴侶動物骨關節炎市場規模及趨勢分析（依通路分類）（2021-2033 年）
  • 獸醫院/診所
  • 電子商務
  • 其他

8. 伴侶動物骨關節炎市場：區域、預測與趨勢分析

  • 區域儀錶板
  • 2025 年及 2033 年各地區伴侶動物骨關節炎市場佔有率
  • 區域展望
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭情勢

  • 市場參與企業分類
  • 公司特定市場分析/堆圖分析
  • 公司簡介
    • Zoetis
    • Boehringer Ingelheim
    • Elanco Animal Health
    • American Regent, Inc.
    • Merck Animal Health（Merck & Co. Inc）
    • Vetoquinol SA
    • Ceva Sante Animale
    • Virbac
    • Ardent Animal Health, Llc
    • PetVivo Holdings, Inc.（Spryng）
    • VetStem Inc.
    • Enso Discoveries
    • Contura Vet US
    • T-Cyte Therapeutics
    • Medrego Llc.
    • Biogenesis Bago
  • 主要企業列表
    • 製造商列表
    • 經銷商列表
Product Code: GVR-4-68040-667-6

Companion Animal Osteoarthritis Market Summary

The global companion animal osteoarthritis market size was estimated at USD 2.98 billion in 2025 and is projected to reach USD 5.22 billion by 2033, growing at a CAGR of 6.46% from 2026 to 2033. The key market growth drivers include advancements in pet treatment, the increasing humanization of pets & expenditure on pets, support programs & initiatives, and changing pet demographics globally.

Advancements in osteoarthritis (OA) treatment for companion animals (CA) are transforming the landscape of veterinary care. With ongoing advancements in veterinary medicine, new therapies and treatment methods for osteoarthritis are becoming increasingly targeted and effective, thereby enhancing the overall management of the condition and improving the quality of life for affected pets.

The development of more effective medications, biologics, and non-pharmaceutical interventions is playing a significant role in this evolution. For example, in recent years, there has been a growing interest in regenerative medicine, including stem cell therapy and platelet-rich plasma (PRP), which have shown promising results in reducing inflammation and promoting healing in joints affected by osteoarthritis. These treatments have become increasingly accessible in veterinary practices, providing pet owners with more options for effective solutions for their pets. According to the American Veterinary Medical Association (AVMA) article in February 2024, advancements in regenerative medicine have significantly improved the treatment of joint conditions like osteoarthritis, helping pets manage pain and improve mobility. Additionally, the rise in precision medicine-where treatments are tailored to the specific needs of individual pets is helping optimize osteoarthritis management.

This approach enables more accurate diagnoses and the administration of therapies that specifically target the underlying causes of osteoarthritis, rather than merely alleviating symptoms. As the veterinary industry continues to evolve toward more specialized and individualized care, these advancements will likely continue to improve outcomes for pets with osteoarthritis. The U.S. Food and Drug Administration (FDA) approved Librela (bedinvetmab) for the control of pain associated with osteoarthritis in dogs on May 5, 2023. This approval marked a significant advancement in veterinary pain management, as Librela became the first and only once-monthly, anti-nerve growth factor (NGF) monoclonal antibody treatment for canine osteoarthritis pain in the United States. Furthermore, the approval of innovative veterinary drugs and treatment modalities plays a crucial role in advancing the osteoarthritis care for companion animals. Similar to the trend in other segments of animal health, regulatory bodies such as the U.S. FDA are approving more treatments aimed at improving joint health

The growing focus on innovation in the treatment of osteoarthritis, supported by rising veterinary care expenditures and increasing pet health awareness, is driving demand for advanced solutions. Pet owners are increasingly willing to invest in advanced treatments that enhance their pets' quality of life, driving greater market growth in osteoarthritis care. A survey by Talker Research for MetLife found that in 2024, the average pet parent spent USD 2,085.60 on their pets. Despite rising inflation, 36% of respondents anticipated spending even more in 2025, indicating a growing willingness to invest in pet health.

These ongoing advancements, combined with the growing adoption of pet insurance and increasing focus on animal health, are expected to further fuel demand for innovative osteoarthritis treatments. As the field of veterinary health evolves and new technologies emerge, the ability to better manage osteoarthritis in companion animals will continue to improve, driving further expansion of this specialized market.

Global Companion Animal Osteoarthritis Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the companion animal osteoarthritis market report based on product, animal, route of administration, distribution channel, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Biologics
    • Stem Cells
    • Platelet-Rich Plasma (PRP)
    • Monoclonal Antibodies (mAb)
    • Other Biologics
  • Viscosupplements
  • Pharmaceuticals
    • Steroids
    • NSAIDS
    • Others
  • Nutritional Supplements
    • Chondroitin
    • Glucosamine
    • Methylsulfonylmethane (MSM)
    • Hyaluronic Acid (HA)
    • Omega-3 Fatty Acids
    • Others
  • Animal Outlook (Revenue, USD Million, 2021 - 2033)
  • Canine
  • Equine
  • Feline
  • Route of Administration Outlook (Revenue, USD Million, 2021 - 2033)
  • Oral
  • Injectable
    • Intra-muscular
    • Intra-articular
    • Other Injectable
  • Others
  • Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Veterinary Hospitals/Clinics
  • E-commerce
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • India
    • China
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources
    • 1.3.4. Primary Research
  • 1.4. Information/Data Analysis
  • 1.5. Market Formulation & Visualization
  • 1.6. Data Validation & Publishing
  • 1.7. Model Details
    • 1.7.1. Model 1 Analysis
    • 1.7.2. Model 2 Analysis
    • 1.7.3. Model 3 Analysis
  • 1.8. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Companion Animal Osteoarthritis Market Variable Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market
    • 3.1.2. Ancillary Market
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Advancements in Treatment for Pets
      • 3.2.1.2. Increasing Humanization of Pets & Expenditure on Pets
      • 3.2.1.3. Support Programs & Initiatives
      • 3.2.1.4. Changing Pet Demographics Globally
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Adverse Drug Reactions (ADR) in Treatments
      • 3.2.2.2. High Treatment Costs
      • 3.2.2.3. Complex Regulation Requirements
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Challenge Analysis
  • 3.3. Companion Animal Osteoarthritis Market Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL by SWOT Analysis
  • 3.4. Estimated Animal Population, by Key Species, by Key Countries, 2021-2024
  • 3.5. Product Pipeline Analysis

Chapter 4. Companion Animal Osteoarthritis Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Companion Animal Osteoarthritis Market: Product Movement Analysis
  • 4.3. Companion Animal Osteoarthritis Market Size & Trend Analysis, by product, 2021 to 2033 (USD Million)
  • 4.4. Biologics
    • 4.4.1. Biologics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.2. Stem Cells
      • 4.4.2.1. Stem Cells Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.3. Platelet-Rich Plasma (PRP)
      • 4.4.3.1. Platelet-Rich Plasma (PRP) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.4. Monoclonal Antibodies (mAb)
      • 4.4.4.1. Monoclonal Antibodies (mAb) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.5. Other Biologics
      • 4.4.5.1. Other Biologics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Viscosupplements
    • 4.5.1. Viscosupplements Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Pharmaceuticals
    • 4.6.1. Pharmaceuticals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.2. Steroids
      • 4.6.2.1. Steroids Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.3. NSAIDs
      • 4.6.3.1. NSAIDs Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.4. Others
      • 4.6.4.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Nutritional Supplements
    • 4.7.1. Nutritional Supplements Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.7.2. Chondroitin
      • 4.7.2.1. Chondroitin Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.7.3. Glucosamine
      • 4.7.3.1. Glucosamine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.7.4. Methylsulfonylmethane (MSM)
      • 4.7.4.1. Methylsulfonylmethane (MSM) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.7.5. Hyaluronic Acid (HA)
      • 4.7.5.1. Hyaluronic Acid (HA) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.7.6. Omega-3 Fatty Acids
      • 4.7.6.1. Omega-3 Fatty Acids Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.7.7. Others
      • 4.7.7.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Companion Animal Osteoarthritis Market: Animal Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Companion Animal Osteoarthritis Market: Animal Movement Analysis
  • 5.3. Companion Animal Osteoarthritis Market Size & Trend Analysis, by animal, 2021 to 2033 (USD Million)
  • 5.4. Canine
    • 5.4.1. Canine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Feline
    • 5.5.1. Feline Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Equine
    • 5.6.1. Equine Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Companion Animal Osteoarthritis Market: Route of Administration Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Companion Animal Osteoarthritis Market: By Route of Administration Movement Analysis
  • 6.3. Companion Animal Osteoarthritis Market Size & Trend Analysis, by route of administration, 2021 to 2033 (USD Million)
  • 6.4. Oral
    • 6.4.1. Oral Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Injectable
    • 6.5.1. Injectable Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.2. Intra-muscular
      • 6.5.2.1. Intra-muscular Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.3. Intra-articular
      • 6.5.3.1. Intra-articular Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.4. Other Injectable
      • 6.5.4.1. Other Injectable Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Others
    • 6.6.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Companion Animal Osteoarthritis Market: By Distribution Channel Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Companion Animal Osteoarthritis Market: By Distribution Channel Movement Analysis
  • 7.3. Companion Animal Osteoarthritis Market Size & Trend Analysis, by distribution channel, 2021 to 2033 (USD Million)
  • 7.4. Veterinary Hospitals/Clinics
    • 7.4.1. Veterinary Hospitals/Clinics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. E-commerce
    • 7.5.1. E-commerce Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Others
    • 7.6.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Companion Animal Osteoarthritis Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Dashboard
  • 8.2. Companion Animal Osteoarthritis Market Share, By Region, 2025 & 2033 (USD Million)
  • 8.3. Regional Outlook
  • 8.4. North America
    • 8.4.1. North America Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.4.2. U.S.
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. U.S. Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.4.3. Canada
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Canada Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.4.4. Mexico
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. Mexico Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.5. Europe
    • 8.5.1. Europe Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.5.2. UK
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. UK Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.5.3. Germany
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Germany Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.5.4. France
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. France Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.5.5. Italy
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Competitive Scenario
      • 8.5.5.3. Regulatory Framework
      • 8.5.5.4. Italy Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.5.6. Spain
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Competitive Scenario
      • 8.5.6.3. Regulatory Framework
      • 8.5.6.4. Spain Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.5.7. Denmark
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competitive Scenario
      • 8.5.7.3. Regulatory Framework
      • 8.5.7.4. Denmark Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.5.8. Sweden
      • 8.5.8.1. Key Country Dynamics
      • 8.5.8.2. Competitive Scenario
      • 8.5.8.3. Regulatory Framework
      • 8.5.8.4. Sweden Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.5.9. Norway
      • 8.5.9.1. Key Country Dynamics
      • 8.5.9.2. Competitive Scenario
      • 8.5.9.3. Regulatory Framework
      • 8.5.9.4. Norway Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Asia Pacific Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.6.2. Japan
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Japan Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.6.3. China
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. China Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.6.4. India
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Competitive Scenario
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. India Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.6.5. Australia
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Competitive Scenario
      • 8.6.5.3. Regulatory Framework
      • 8.6.5.4. Australia Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.6.6. South Korea
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Competitive Scenario
      • 8.6.6.3. Regulatory Framework
      • 8.6.6.4. South Korea Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.6.7. Thailand
      • 8.6.7.1. Key Country Dynamics
      • 8.6.7.2. Competitive Scenario
      • 8.6.7.3. Regulatory Framework
      • 8.6.7.4. Thailand Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Latin America Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Framework
      • 8.7.2.4. Brazil Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033
    • 8.7.3. Argentina
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Framework
      • 8.7.3.4. Argentina Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.8. Middle East & Africa
    • 8.8.1. Middle East & Africa Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. Key Country Dynamics
      • 8.8.2.2. Competitive Scenario
      • 8.8.2.3. Regulatory Framework
      • 8.8.2.4. South Africa Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key Country Dynamics
      • 8.8.3.2. Competitive Scenario
      • 8.8.3.3. Regulatory Framework
      • 8.8.3.4. Saudi Arabia Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.8.4. UAE
      • 8.8.4.1. Key Country Dynamics
      • 8.8.4.2. UAE Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.8.5. Kuwait
      • 8.8.5.1. Key Country Dynamics
      • 8.8.5.2. Competitive Scenario
      • 8.8.5.3. Regulatory Framework
      • 8.8.5.4. Kuwait Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
  • 9.2. Company Market Position Analysis/ Heap Map Analysis
  • 9.3. Company Profiles
    • 9.3.1. Zoetis
      • 9.3.1.1. Participant's Overview
      • 9.3.1.2. Financial Performance
      • 9.3.1.3. Product Benchmarking
      • 9.3.1.4. Strategic Initiatives
    • 9.3.2. Boehringer Ingelheim
      • 9.3.2.1. Participant's Overview
      • 9.3.2.2. Financial Performance
      • 9.3.2.3. Product Benchmarking
      • 9.3.2.4. Strategic Initiatives
    • 9.3.3. Elanco Animal Health
      • 9.3.3.1. Participant's Overview
      • 9.3.3.2. Financial Performance
      • 9.3.3.3. Product Benchmarking
      • 9.3.3.4. Strategic Initiatives
    • 9.3.4. American Regent, Inc.
      • 9.3.4.1. Participant's Overview
      • 9.3.4.2. Financial Performance
      • 9.3.4.3. Product Benchmarking
      • 9.3.4.4. Strategic Initiatives
    • 9.3.5. Merck Animal Health (Merck & Co. Inc)
      • 9.3.5.1. Participant's Overview
      • 9.3.5.2. Financial Performance
      • 9.3.5.3. Product Benchmarking
      • 9.3.5.4. Strategic Initiatives
    • 9.3.6. Vetoquinol S.A.
      • 9.3.6.1. Participant's Overview
      • 9.3.6.2. Financial Performance
      • 9.3.6.3. Product Benchmarking
      • 9.3.6.4. Strategic Initiatives
    • 9.3.7. Ceva Sante Animale
      • 9.3.7.1. Participant's Overview
      • 9.3.7.2. Financial Performance
      • 9.3.7.3. Product Benchmarking
      • 9.3.7.4. Strategic Initiatives
    • 9.3.8. Virbac
      • 9.3.8.1. Participant's Overview
      • 9.3.8.2. Financial Performance
      • 9.3.8.3. Product Benchmarking
      • 9.3.8.4. Strategic Initiatives
    • 9.3.9. Ardent Animal Health, Llc
      • 9.3.9.1. Participant's Overview
      • 9.3.9.2. Financial Performance
      • 9.3.9.3. Product Benchmarking
      • 9.3.9.4. Strategic Initiatives
    • 9.3.10. PetVivo Holdings, Inc. (Spryng)
      • 9.3.10.1. Participant's Overview
      • 9.3.10.2. Financial Performance
      • 9.3.10.3. Product Benchmarking
      • 9.3.10.4. Strategic Initiatives
    • 9.3.11. VetStem Inc.
      • 9.3.11.1. Participant's Overview
      • 9.3.11.2. Financial Performance
      • 9.3.11.3. Product Benchmarking
      • 9.3.11.4. Strategic Initiatives
    • 9.3.12. Enso Discoveries
      • 9.3.12.1. Participant's Overview
      • 9.3.12.2. Financial Performance
      • 9.3.12.3. Product Benchmarking
      • 9.3.12.4. Strategic Initiatives
    • 9.3.13. Contura Vet US
      • 9.3.13.1. Participant's Overview
      • 9.3.13.2. Financial Performance
      • 9.3.13.3. Product Benchmarking
      • 9.3.13.4. Strategic Initiatives
    • 9.3.14. T-Cyte Therapeutics
      • 9.3.14.1. Participant's Overview
      • 9.3.14.2. Financial Performance
      • 9.3.14.3. Product Benchmarking
      • 9.3.14.4. Strategic Initiatives
    • 9.3.15. Medrego Llc.
      • 9.3.15.1. Participant's Overview
      • 9.3.15.2. Financial Performance
      • 9.3.15.3. Product Benchmarking
      • 9.3.15.4. Strategic Initiatives
    • 9.3.16. Biogenesis Bago
      • 9.3.16.1. Participant's Overview
      • 9.3.16.2. Financial Performance
      • 9.3.16.3. Product Benchmarking
      • 9.3.16.4. Strategic Initiatives
  • 9.4. List of Key Companies
    • 9.4.1. List of Manufacturers
    • 9.4.2. List of Distributors

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
  • Table 4 Global Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
  • Table 5 Global Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 6 Global Companion Animal Osteoarthritis Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 7 Global Companion Animal Osteoarthritis Market, by Region, 2021 - 2033 (USD Million)
  • Table 8 North America Companion Animal Osteoarthritis Market, by Country, 2021 - 2033 (USD Million)
  • Table 9 North America Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
  • Table 10 North America Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
  • Table 11 North America Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 12 North America Companion Animal Osteoarthritis Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 13 U.S. Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
  • Table 14 U.S. Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
  • Table 15 U.S. Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 16 U.S. Companion Animal Osteoarthritis Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 17 Canada Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
  • Table 18 Canada Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
  • Table 19 Canada Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 20 Canada Companion Animal Osteoarthritis Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 21 Mexico Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
  • Table 22 Mexico Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
  • Table 23 Mexico Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 24 Mexico Companion Animal Osteoarthritis Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 25 Europe Companion Animal Osteoarthritis Market, by Country, 2021 - 2033 (USD Million)
  • Table 26 Europe Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
  • Table 27 Europe Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
  • Table 28 Europe Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 29 Europe Companion Animal Osteoarthritis Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 30 UK Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
  • Table 31 UK Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
  • Table 32 UK Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 33 UK Companion Animal Osteoarthritis Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 34 Germany Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
  • Table 35 Germany Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
  • Table 36 Germany Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 37 Germany Companion Animal Osteoarthritis Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 38 France Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
  • Table 39 France Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
  • Table 40 France Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 41 France Companion Animal Osteoarthritis Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 42 Italy Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
  • Table 43 Italy Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
  • Table 44 Italy Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 45 Italy Companion Animal Osteoarthritis Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 46 Spain Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
  • Table 47 Spain Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
  • Table 48 Spain Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 49 Spain Companion Animal Osteoarthritis Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 50 Denmark Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
  • Table 51 Denmark Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
  • Table 52 Denmark Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 53 Denmark Companion Animal Osteoarthritis Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 54 Sweden Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
  • Table 55 Sweden Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
  • Table 56 Sweden Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 57 Sweden Companion Animal Osteoarthritis Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 58 Norway Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
  • Table 59 Norway Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
  • Table 60 Norway Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 61 Norway Companion Animal Osteoarthritis Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 62 Asia Pacific Companion Animal Osteoarthritis Market, by Country, 2021 - 2033 (USD Million)
  • Table 63 Asia Pacific Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
  • Table 64 Asia Pacific Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
  • Table 65 Asia Pacific Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 66 Asia Pacific Companion Animal Osteoarthritis Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 67 China Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
  • Table 68 China Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
  • Table 69 China Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 70 China Companion Animal Osteoarthritis Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 71 Japan Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
  • Table 72 Japan Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
  • Table 73 Japan Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 74 Japan Companion Animal Osteoarthritis Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 75 India Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
  • Table 76 India Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
  • Table 77 India Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 78 India Companion Animal Osteoarthritis Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 79 South Korea Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
  • Table 80 South Korea Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
  • Table 81 South Korea Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 82 South Korea Companion Animal Osteoarthritis Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 83 Australia Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
  • Table 84 Australia Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
  • Table 85 Australia Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 86 Australia Companion Animal Osteoarthritis Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 87 Thailand Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
  • Table 88 Thailand Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
  • Table 89 Thailand Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 90 Thailand Companion Animal Osteoarthritis Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 91 Latin America Companion Animal Osteoarthritis Market, by Country, 2021 - 2033 (USD Million)
  • Table 92 Latin America Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
  • Table 93 Latin America Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
  • Table 94 Latin America Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 95 Latin America Companion Animal Osteoarthritis Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 96 Brazil Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
  • Table 97 Brazil Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
  • Table 98 Brazil Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 99 Brazil Companion Animal Osteoarthritis Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 100 Brazil Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
  • Table 101 Argentina Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
  • Table 102 Argentina Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 103 Argentina Companion Animal Osteoarthritis Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 104 Middle East & Africa Companion Animal Osteoarthritis Market, by Country, 2021 - 2033 (USD Million)
  • Table 105 Middle East & Africa Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
  • Table 106 Middle East & Africa Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
  • Table 107 Middle East & Africa Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 108 Middle East & Africa Companion Animal Osteoarthritis Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 109 South Africa Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
  • Table 110 South Africa Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
  • Table 111 South Africa Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 112 South Africa Companion Animal Osteoarthritis Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 113 Saudi Arabia Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
  • Table 114 Saudi Arabia Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
  • Table 115 Saudi Arabia Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 116 Saudi Arabia Companion Animal Osteoarthritis Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 117 UAE Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
  • Table 118 UAE Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
  • Table 119 UAE Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 120 UAE Companion Animal Osteoarthritis Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 121 Kuwait Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
  • Table 122 Kuwait Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
  • Table 123 Kuwait Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 124 Kuwait Companion Animal Osteoarthritis Market, By Distribution Channel, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Companion Animal Osteoarthritis Market, Market Segmentation
  • Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Regional Marketplace: Key Takeaways
  • Fig. 14 Global Companion Animal Osteoarthritis Market, for By Product, 2021 - 2033 (USD Million)
  • Fig. 15 Global Companion Animal Osteoarthritis Market, for Biologics, 2021 - 2033 (USD Million)
  • Fig. 16 Global Companion Animal Osteoarthritis Market, for Stem Cells, 2021 - 2033 (USD Million)
  • Fig. 17 Global Companion Animal Osteoarthritis Market, for Platelet-Rich Plasma (PRP), 2021 - 2033 (USD Million)
  • Fig. 18 Global Companion Animal Osteoarthritis Market, for Monoclonal Antibodies (mAb), 2021 - 2033 (USD Million)
  • Fig. 19 Global Companion Animal Osteoarthritis Market, for Other Biologics, 2021 - 2033 (USD Million)
  • Fig. 20 Global Companion Animal Osteoarthritis Market, for Viscosupplements, 2021 - 2033 (USD Million)
  • Fig. 21 Global Companion Animal Osteoarthritis Market, for Pharmaceuticals, 2021 - 2033 (USD Million)
  • Fig. 22 Global Companion Animal Osteoarthritis Market, for Steroids, 2021 - 2033 (USD Million)
  • Fig. 23 Global Companion Animal Osteoarthritis Market, for NSAIDS, 2021 - 2033 (USD Million)
  • Fig. 24 Global Companion Animal Osteoarthritis Market, for Others, 2021 - 2033 (USD Million)
  • Fig. 25 Global Companion Animal Osteoarthritis Market, for Nutritional Supplements, 2021 - 2033 (USD Million)
  • Fig. 26 Global Companion Animal Osteoarthritis Market, for Chondroitin, 2021 - 2033 (USD Million)
  • Fig. 27 Global Companion Animal Osteoarthritis Market, for Glucosamine, 2021 - 2033 (USD Million)
  • Fig. 28 Global Companion Animal Osteoarthritis Market, for Methylsulfonylmethane (MSM), 2021 - 2033 (USD Million)
  • Fig. 29 Global Companion Animal Osteoarthritis Market, for Hyaluronic Acid (HA), 2021 - 2033 (USD Million)
  • Fig. 30 Global Companion Animal Osteoarthritis Market, for Omega-3 Fatty Acids, 2021 - 2033 (USD Million)
  • Fig. 31 Global Companion Animal Osteoarthritis Market, for Others, 2021 - 2033 (USD Million)
  • Fig. 32 Global Companion Animal Osteoarthritis Market, for By Animal, 2021 - 2033 (USD Million)
  • Fig. 33 Global Companion Animal Osteoarthritis Market, for Canine, 2021 - 2033 (USD Million)
  • Fig. 34 Global Companion Animal Osteoarthritis Market, for Equine, 2021 - 2033 (USD Million)
  • Fig. 35 Global Companion Animal Osteoarthritis Market, for Feline, 2021 - 2033 (USD Million)
  • Fig. 36 Global Companion Animal Osteoarthritis Market, for By Route of Administration, 2021 - 2033 (USD Million)
  • Fig. 37 Global Companion Animal Osteoarthritis Market, for Oral, 2021 - 2033 (USD Million)
  • Fig. 38 Global Companion Animal Osteoarthritis Market, for Injectable, 2021 - 2033 (USD Million)
  • Fig. 39 Global Companion Animal Osteoarthritis Market, for Intra-muscular, 2021 - 2033 (USD Million)
  • Fig. 40 Global Companion Animal Osteoarthritis Market, for Intra-articular, 2021 - 2033 (USD Million)
  • Fig. 41 Global Companion Animal Osteoarthritis Market, for Other Injectable, 2021 - 2033 (USD Million)
  • Fig. 42 Global Companion Animal Osteoarthritis Market, for Others, 2021 - 2033 (USD Million)
  • Fig. 43 Global Companion Animal Osteoarthritis Market, for By Distribution Channel, 2021 - 2033 (USD Million)
  • Fig. 44 Global Companion Animal Osteoarthritis Market, for Veterinary Hospitals/Clinics, 2021 - 2033 (USD Million)
  • Fig. 45 Global Companion Animal Osteoarthritis Market, for E-commerce, 2021 - 2033 (USD Million)
  • Fig. 46 Global Companion Animal Osteoarthritis Market, for Others, 2021 - 2033 (USD Million)
  • Fig. 47 Regional Outlook, 2025 & 2033
  • Fig. 48 North America Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
  • Fig. 49 U.S. Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
  • Fig. 50 Canada Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
  • Fig. 51 Mexico Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
  • Fig. 52 Europe Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
  • Fig. 53 UK Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
  • Fig. 54 Germany Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
  • Fig. 55 France Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
  • Fig. 56 Italy Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
  • Fig. 57 Spain Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
  • Fig. 58 Sweden Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
  • Fig. 59 Denmark Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
  • Fig. 60 Norway Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
  • Fig. 61 Asia Pacific Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
  • Fig. 62 Japan Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
  • Fig. 63 China Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
  • Fig. 64 India Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
  • Fig. 65 Australia Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
  • Fig. 66 South Korea Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
  • Fig. 67 Thailand Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
  • Fig. 68 Latin America Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
  • Fig. 69 Brazil Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
  • Fig. 70 Argentina Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
  • Fig. 71 Middle East and Africa Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
  • Fig. 72 South Africa Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
  • Fig. 73 Saudi Arabia Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
  • Fig. 74 UAE Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
  • Fig. 75 Kuwait Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)